Oral ibuprofen for treatment of patent ductus arteriosus: More than a cheap alternative?: More

Neonatology

Volumn 102, Issue 3, 2012, Pages 196-

  Erdeve, Omer ^a   Yurttutan, Sadk ^b   Ozdemir, Ramazan ^b   Dilmen, Ugur ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b Zekai Tahir Burak Maternity Teaching Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN;

BREAST MILK; DRUG ADMINISTRATION ROUTE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; EXTREMELY LOW BIRTH WEIGHT; LETTER; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL;

CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; HUMANS; IBUPROFEN; INDOMETHACIN;

EID: 84866914684     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000339552     Document Type: Letter

References (5)

1. Neumann R, Schulzke SM, Buhrer C: Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology 2012; 102: 9-15.
2. Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, Oguz SS, Uras N: Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2012; 97:F279-F283.
3. Walther FJ. Oral ibuprofen for patent ductus arteriosus: effective and safe or just cheap? Neonatology 2012; 102: 16-18.
4. Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U: Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr 2011; 158: 549-554.e1.
5. Erdeve O, Sarici SU, Sari E, Gok F: Oral-ibuprofen- induced acute renal failure in a preterm infant. Pediatr Nephrol 2008; 23: 1565-1567.